400mg Capivasertib 64-tabs $199

Capivasertib is an AKT inhibitor. It’s made especially for breast cancer patients who have changes in PIK3CA, AKT1, or PTEN and are HR /HER2 positive. It works by stopping the AKT signaling pathway.

You can get the drug in 200 mg or 400 mg tablets. For the HR /HER2breast cancer indication, the recommended dose is 400 mg taken twice daily, with treatment administered for 4 consecutive days followed by 3 days off. Each bottle comes with 64 tablets.

The way you take it is in cycles—4 days on, 3 days off. It keeps things steady and on track.